Nutritional Historical Cash Flow

NGS Stock

0.04 0.00 0.00%

Analysis of Nutritional Growth cash flow over time is an excellent tool to project Nutritional Growth future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cashflows From Investing Activities of 3.8 K or Other Cashflows From Financing Activities of 291.4 K as it is a great indicator of Nutritional Growth ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Nutritional Growth latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nutritional Growth is a good buy for the upcoming year.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutritional Growth Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Nutritional Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Nutritional balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Nutritional's non-liquid assets can be easily converted into cash.

Nutritional Growth Cash Flow Chart

At this time, Nutritional Growth's Change To Inventory is comparatively stable compared to the past year. Change In Working Capital is likely to gain to about 797.3 K in 2024, whereas Free Cash Flow is likely to drop (2.5 M) in 2024.

Begin Period Cash Flow Depreciation Dividends Paid Capital Expenditures Change To Operating Activities

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Depreciation

Depreciation indicates how much of Nutritional Growth value has been used up. For tax purposes Nutritional Growth can deduct the cost of the tangible assets it purchases as business expenses. However, Nutritional Growth Solutions must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Nutritional Growth to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Nutritional Growth operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most accounts from Nutritional Growth's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Nutritional Growth current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutritional Growth Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2023	2024 (projected)
Capital Expenditures	2.38	2.26
Dividends Paid	348.4K	309.6K

Capital Expenditures Dividends Paid

Nutritional Growth cash flow statement Correlations

	Change To Inventory	Change In Cash	Net Borrowings	Free Cash Flow	Change In Working Capital	Begin Period Cash Flow	Depreciation	Other Non Cash Items	Dividends Paid	Capital Expenditures	Change To Account Receivables	Change To Operating Activities	Net Income	End Period Cash Flow	Change To Netincome	Change To Liabilities	Sale Purchase Of Stock	Investments	Issuance Of Capital Stock
Change To Inventory		0.24	0.01	0.45	0.92	-0.57	-0.07	0.16	-0.6	-0.05	0.3	-0.1	0.29	-0.24	0.05	0.0	-0.11	0.02	-0.19
Change In Cash	0.24		0.49	0.52	0.44	-0.5	-0.45	0.37	0.27	0.64	-0.74	0.49	0.23	0.7	0.59	0.65	0.48	-0.55	0.49
Net Borrowings	0.01	0.49		0.79	0.26	0.17	-0.96	-0.27	0.62	0.18	-0.39	0.95	0.72	0.71	-0.08	0.53	0.99	-0.87	0.94
Free Cash Flow	0.45	0.52	0.79		0.73	0.08	-0.82	-0.45	0.23	-0.03	-0.14	0.72	0.94	0.62	-0.31	0.72	0.73	-0.7	0.67
Change In Working Capital	0.92	0.44	0.26	0.73		-0.43	-0.35	-0.06	-0.41	-0.09	0.09	0.19	0.58	0.09	-0.08	0.39	0.15	-0.2	0.06
Begin Period Cash Flow	-0.57	-0.5	0.17	0.08	-0.43		-0.18	-0.81	0.44	-0.32	0.35	0.12	0.37	0.26	-0.75	0.12	0.25	-0.24	0.31
Depreciation	-0.07	-0.45	-0.96	-0.82	-0.35	-0.18		0.32	-0.43	-0.01	0.38	-0.95	-0.77	-0.63	0.18	-0.58	-0.94	0.77	-0.86
Other Non Cash Items	0.16	0.37	-0.27	-0.45	-0.06	-0.81	0.32		-0.23	0.61	-0.36	-0.26	-0.73	-0.24	0.95	-0.39	-0.27	0.2	-0.26
Dividends Paid	-0.6	0.27	0.62	0.23	-0.41	0.44	-0.43	-0.23		0.44	-0.37	0.56	0.24	0.74	0.05	0.31	0.69	-0.73	0.8
Capital Expenditures	-0.05	0.64	0.18	-0.03	-0.09	-0.32	-0.01	0.61	0.44		-0.37	0.03	-0.29	0.47	0.79	0.01	0.23	-0.52	0.38
Change To Account Receivables	0.3	-0.74	-0.39	-0.14	0.09	0.35	0.38	-0.36	-0.37	-0.37		-0.57	0.04	-0.56	-0.55	-0.56	-0.41	0.25	-0.38
Change To Operating Activities	-0.1	0.49	0.95	0.72	0.19	0.12	-0.95	-0.26	0.56	0.03	-0.57		0.66	0.66	-0.08	0.61	0.93	-0.7	0.85
Net Income	0.29	0.23	0.72	0.94	0.58	0.37	-0.77	-0.73	0.24	-0.29	0.04	0.66		0.54	-0.61	0.68	0.67	-0.6	0.61
End Period Cash Flow	-0.24	0.7	0.71	0.62	0.09	0.26	-0.63	-0.24	0.74	0.47	-0.56	0.66	0.54		0.06	0.8	0.76	-0.82	0.83
Change To Netincome	0.05	0.59	-0.08	-0.31	-0.08	-0.75	0.18	0.95	0.05	0.79	-0.55	-0.08	-0.61	0.06		-0.17	-0.06	-0.05	-0.01
Change To Liabilities	0.0	0.65	0.53	0.72	0.39	0.12	-0.58	-0.39	0.31	0.01	-0.56	0.61	0.68	0.8	-0.17		0.52	-0.46	0.5
Sale Purchase Of Stock	-0.11	0.48	0.99	0.73	0.15	0.25	-0.94	-0.27	0.69	0.23	-0.41	0.93	0.67	0.76	-0.06	0.52		-0.9	0.98
Investments	0.02	-0.55	-0.87	-0.7	-0.2	-0.24	0.77	0.2	-0.73	-0.52	0.25	-0.7	-0.6	-0.82	-0.05	-0.46	-0.9		-0.96
Issuance Of Capital Stock	-0.19	0.49	0.94	0.67	0.06	0.31	-0.86	-0.26	0.8	0.38	-0.38	0.85	0.61	0.83	-0.01	0.5	0.98	-0.96

Click cells to compare fundamentals

Nutritional Growth Account Relationship Matchups

Nutritional Growth cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Change To Inventory	(92.1K)	(10.0K)	(164.2K)	(1.4M)	573.4K	602.0K
Change In Cash	(2.6M)	3.1M	(353.7K)	(2.6M)	(1.3M)	(1.3M)
Free Cash Flow	(2.6M)	(1.8M)	(3.7M)	(7.0M)	(2.3M)	(2.5M)
Change In Working Capital	(149.7K)	309.7K	(50.2K)	(1.2M)	759.3K	797.3K
Begin Period Cash Flow	3.4M	444.8K	3.4M	4.1M	1.5M	2.2M
Total Cashflows From Investing Activities	(16K)	(76K)	(87K)	4K	3.6K	3.8K
Other Cashflows From Financing Activities	(23.0K)	2.0M	(7.2K)	(36K)	302K	291.4K
Depreciation	13.0K	11.1K	106.2K	88.0K	96.4K	57.9K
Other Non Cash Items	674.9K	2.8M	874.9K	305.8K	560.0K	927.0K
Capital Expenditures	21.6K	61.4K	57.3K	4K	2.38	2.26
Total Cash From Operating Activities	(2.6M)	(1.7M)	(3.7M)	(7.0M)	(2.4M)	(2.5M)
Change To Account Receivables	168.4K	(184.9K)	138.1K	(13.0K)	114.9K	120.6K
Change To Operating Activities	144K	162K	88K	122K	109.8K	107.5K
Net Income	(2.9M)	(4.9M)	(4.6M)	(6.1M)	(3.0M)	(3.1M)
Total Cash From Financing Activities	5.7M	4.4M	2.5M	2.2M	998K	948.1K
End Period Cash Flow	825.1K	3.6M	3.0M	1.5M	172K	163.4K
Other Cashflows From Investing Activities	(1K)	4.5K	(7.7K)	11.5K	13.3K	13.9K
Change To Netincome	325K	2.5M	906K	216K	248.4K	236.0K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Nutritional Stock Analysis

When running Nutritional Growth's price analysis, check to measure Nutritional Growth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutritional Growth is operating at the current time. Most of Nutritional Growth's value examination focuses on studying past and present price action to predict the probability of Nutritional Growth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutritional Growth's price. Additionally, you may evaluate how the addition of Nutritional Growth to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC